Refining breast cancer biomarker discovery and drug targeting through an advanced data-driven approach.

BMC Bioinformatics · 2024 · PMC10810249 · PMID 38253993

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This subset represents a highly significant group, as these genes are validated both through differential expression analysis and the advanced FS capabilities of the BGWO_SA_Ens algorithm.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.